Your browser doesn't support javascript.
loading
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely, Jason; Dalgard, Olav; Conway, Brian; Cunningham, Evan B; Bruggmann, Philip; Hajarizadeh, Behzad; Amin, Janaki; Bruneau, Julie; Hellard, Margaret; Litwin, Alain H; Marks, Philippa; Quiene, Sophie; Siriragavan, Sharmila; Applegate, Tanya L; Swan, Tracy; Byrne, Jude; Lacalamita, Melanie; Dunlop, Adrian; Matthews, Gail V; Powis, Jeff; Shaw, David; Thurnheer, Maria Christine; Weltman, Martin; Kronborg, Ian; Cooper, Curtis; Feld, Jordan J; Fraser, Chris; Dillon, John F; Read, Phillip; Gane, Ed; Dore, Gregory J.
Affiliation
  • Grebely J; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.
  • Dalgard O; Akershus University Hospital, Oslo, Norway.
  • Conway B; Vancouver Infectious Diseases Center, Vancouver, BC, Canada.
  • Cunningham EB; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Bruggmann P; Arud Centres for Addiction Medicine, Zurich, Switzerland.
  • Hajarizadeh B; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Amin J; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
  • Bruneau J; Centre Hospitalier de l'Université de Montréal, QC, Canada.
  • Hellard M; The Burnet Institute, Melbourne, VIC, Australia; Department of Infectious Disease, The Alfred Hospital, Melbourne, VIC, Australia.
  • Litwin AH; Montefiore Medical Center, United States and Albert Einstein College of Medicine, New York, NY, USA.
  • Marks P; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Quiene S; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Siriragavan S; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Applegate TL; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
  • Swan T; International Network on Hepatitis in Substance Users, New York, NY, USA.
  • Byrne J; Australian Injecting & Illicit Drug Users League, Canberra, NSW, Australia.
  • Lacalamita M; Department of Infectious Diseases, Bern University Hospital, Bern, Switzerland.
  • Dunlop A; Newcastle Pharmacotherapy Service, Newcastle, NSW, Australia.
  • Matthews GV; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
  • Powis J; South Riverdale Community Health Centre, Toronto, ON, Canada.
  • Shaw D; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Thurnheer MC; Department of Infectious Diseases, Bern University Hospital, Bern, Switzerland.
  • Weltman M; Nepean Hospital, Penrith, NSW, Australia.
  • Kronborg I; Footscray Hospital, Footscray, VIC, Australia.
  • Cooper C; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Feld JJ; Toronto General Hospital, Toronto, ON, Canada.
  • Fraser C; Cool Aid Community Health Centre, Victoria, BC, Canada.
  • Dillon JF; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
  • Read P; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Kirketon Road Centre, Sydney, NSW, Australia.
  • Gane E; Auckland City Hospital, Auckland, New Zealand.
  • Dore GJ; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
Lancet Gastroenterol Hepatol ; 3(3): 153-161, 2018 03.
Article in En | MEDLINE | ID: mdl-29310928

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Carbamates / Substance Abuse, Intravenous / Hepatitis C, Chronic / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lancet Gastroenterol Hepatol Year: 2018 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Carbamates / Substance Abuse, Intravenous / Hepatitis C, Chronic / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lancet Gastroenterol Hepatol Year: 2018 Document type: Article Country of publication: Netherlands